INS and Hyperglycemia: A couple of months later, a study by Aguayo-Mazzucato et al. demonstrated that oral treatment with ABT-263 alleviated hyperglycemia and enhanced the β-cell gene expression profile in animals treated with an insulin receptor antagonist (a drug-induced insulin-resistant mouse model).